#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatic cirrhosis Nephropathy Krabbe's disease Congenital leptin deficiency Enteritis Cerebral arteriovenous malformation haemorrhagic Acute lymphocytic leukaemia Chronic hepatitis B Peripheral primitive neuroectodermal tumour of soft tissue Infertility male Shprintzen-Goldberg syndrome Autoinflammation with infantile enterocolitis Frontotemporal dementia Skin angiosarcoma Synovial sarcoma metastatic More trials…

    Learn about Rare Diseases

    Castleman’s disease – Trials in Disease Pemphigoid Wolfram syndrome – Life with Disease Undifferentiated sarcoma – Trials in Disease Usher’s syndrome – Life with Disease Sarcoma – Life with Disease Stevens-Johnson syndrome Acquired haemophilia – Trials in Disease Pulmonary sarcoidosis Anaplastic thyroid cancer – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mps-215 Other Blood Products Arbaclofen Glatiramer Acetate Trastuzumab Deruxtecan Jnj-81241459 HYDROGEN Ly3298176 Rosnilimab Nizatidine Ziprasidone Febuxostat Hemihydrate Daxdilimab Doxylamine Hydrogen Succinate Nirogacestat Hydrobromide Piracetam Ladarixin Triamcinolone Pp1493 Dexchlorpheniramine Maleate More therapies…

    Learn about Your Condition

    Bacterial vaginosis Keratosis follicular Lupus nephritis B-cell lymphoma refractory Fracture infection Postoperative wound infection Atrophic vulvovaginitis Cold urticaria BK virus infection Leiomyosarcoma Endocarditis enterococcal VEXAS syndrome Angiosarcoma metastatic Piriformis syndrome Marfan's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Bi 706321
    • Ustekinumab
    Czechia Germany Hungary Italy Poland Spain

  • Study on MaaT013 for Treating Acute Gastrointestinal Graft-Versus-Host Disease in Patients Not Responding to Ruxolitinib

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Acute graft versus host disease in intestine
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Austria Belgium France Germany Italy Spain

  • Study on GS-1427 for Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Gs-1427
    Austria Belgium Czechia France Germany Hungary +4

  • Study on Reducing Chemotherapy for Patients with Low-Risk Localized Gastroesophageal Cancer Using Docetaxel, Oxaliplatin, Calcium Folinate, and Fluorouracil

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Calcium Folinate
    • Docetaxel
    • Fluorouracil
    France

  • Study on the Effectiveness and Safety of Golimumab for Children with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Golimumab
    France Italy Poland

  • Study on the Safety and Effectiveness of Naronapride for Adults with Moderate Idiopathic or Diabetic Gastroparesis

    Not recruiting

    2 1
    Investigated Diseases:
    • Diabetic gastroparesis
    • Impaired gastric emptying
    Investigated Drugs:
    • Naronapride Dihydrochloride Trihydrate
    Austria Belgium France Germany Italy Latvia +2
Previous Page
1 … 65 66 67 68 69 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!